STAA
STAAR Surgical Company · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website aar.com
- Employees(FY) 882
- ISIN US8523123052
Performance
+3.9%
1W
-2.94%
1M
-16.23%
3M
-33.25%
6M
-11.18%
YTD
-14.15%
1Y
Profile
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Technical Analysis of STAA 2024-12-02
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-26 19:00
STAA: Raising target price to $22.00(Argus Research)
- 2024-11-25 07:00
STAAR Surgical to Participate in BTIG Ophthalmology Day(Business Wire)
- 2024-11-24 18:00
STAAR Surgical to Participate in BTIG Ophthalmology Day(Businesswire)
- 2024-11-13 10:05
- 2024-11-13 07:00
- 2024-11-12 19:00
STAA: Lowering target price to $23.00(Argus Research)
- 2024-11-12 18:00
- 2024-11-05 19:00
STAA: What does Argus have to say about STAA?(Argus Research)
- 2024-11-04 09:15
- 2024-11-03 16:15
- 2024-11-02 08:41
- 2024-11-01 21:00
- 2024-11-01 07:04
STAAR Surgical Third Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
- 2024-10-30 22:21
- 2024-10-30 17:35
- 2024-10-30 16:33
Staar Surgical: Q3 Earnings Snapshot(Associated Press Finance)
- 2024-10-30 04:01
STAAR Surgical Reports Third Quarter 2024 Results(Businesswire)
- 2024-10-28 21:11
- 2024-10-24 06:48
- 2024-10-23 07:00
- 2024-10-22 19:00
- 2024-10-08 20:00
STAA: Rating increased to a HOLD(Argus Research)
- 2024-10-07 09:55
- 2024-09-27 09:55
- 2024-09-27 06:09
Returns At STAAR Surgical (NASDAQ:STAA) Appear To Be Weighed Down(Simply Wall St.)
- 2024-09-23 07:00
- 2024-09-22 19:00
- 2024-09-17 08:00
- 2024-09-16 20:00
- 2024-09-16 12:00
Page 1 of 9
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.